Ontology highlight
ABSTRACT: Objectives
The aim of this study was to prospectively survey transmitted drug resistance (TDR) among recently infected individuals (mostly MSM).Methods
TDR was determined in prospective annual cohorts of recently HIV-1-infected individuals consecutively recruited from 2008 to 2010. Resistance interpretation was carried out using Stanford Database tools and the WHO surveillance drug resistance mutation list. Kruskal-Wallis and Fisher's exact tests were used to compare demographic and laboratory outcomes.Results
A total of 299 subjects were enrolled, with 89% MSM. Median viral load was significantly higher in 2010 than in 2008 (P=0.004). Of the 284 analysable reverse transcriptase/protease sequences, TDR to any drug was found in 14/284 (4.9%); 4.0% in 2008, 5.9% in 2009 and 5.3% in 2010, with an increasing trend of TDR to NRTIs and NNRTIs from 2008 to 2010 (P=0.07). Good correlation was found between our data and the WHO threshold surveillance method. Only rilpivirine had significantly higher (P<0.05) predicted resistance in 2010 than in 2008 and 2009.Conclusions
A trend towards an increase in TDR in Thailand where the major epidemic is among MSM was observed, but did not reach the WHO-defined high-level threshold (>15%). Attention to prevent the development and spread of drug resistance is needed.
SUBMITTER: Sirivichayakul S
PROVIDER: S-EPMC4375389 | biostudies-literature | 2015 Apr
REPOSITORIES: biostudies-literature
Sirivichayakul Sunee S Kantor Rami R DeLong Allison K AK Wongkunya Rapeeporn R Mekprasan Suwanna S Ruxrungtham Kiat K Sohn Annette H AH Phanuphak Praphan P
The Journal of antimicrobial chemotherapy 20141218 4
<h4>Objectives</h4>The aim of this study was to prospectively survey transmitted drug resistance (TDR) among recently infected individuals (mostly MSM).<h4>Methods</h4>TDR was determined in prospective annual cohorts of recently HIV-1-infected individuals consecutively recruited from 2008 to 2010. Resistance interpretation was carried out using Stanford Database tools and the WHO surveillance drug resistance mutation list. Kruskal-Wallis and Fisher's exact tests were used to compare demographic ...[more]